ABVC BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	9	8	20	97	-	-
Market Cap Growth	-34.66%	-58.87%	-78.97%	-	-	-
Enterprise Value	11	10	22	93	1	4
PE Ratio	-	-0.80	-1.24	-7.55	-	-
PS Ratio	357.80	55.04	21.03	272.59	-	-
PB Ratio	1.16	1.00	6.58	10.97	-	-
P/FCF Ratio	-4.28	-1.97	-2.71	-12.74	-	-
P/OCF Ratio	-4.31	-1.98	-2.76	-12.77	-	-
EV/Sales Ratio	423.90	64.76	22.67	262.58	3.07	6.30
EV/EBITDA Ratio	-1.68	-1.28	-1.44	-7.93	-0.15	-1.39
EV/EBIT Ratio	-1.68	-1.27	-1.43	-7.93	-0.15	-1.37
EV/FCF Ratio	-4.80	-2.32	-2.92	-12.27	-0.32	-1.41
Debt / Equity Ratio	0.31	0.27	0.99	0.35	1.89	-30.33
Debt / EBITDA Ratio	-0.26	-0.29	-0.20	-0.26	-0.68	-1.44
Debt / FCF Ratio	-0.75	-0.54	-0.41	-0.41	-1.42	-1.46
Quick Ratio	0.25	0.26	0.51	1.92	1.24	0.12
Current Ratio	0.27	0.28	0.54	2.07	1.27	0.13
Asset Turnover	0.00	0.01	0.08	0.03	0.05	-
Interest Coverage	-2.96	-3.11	-52.15	-51.88	-23.72	-6.72
Return on Equity (ROE)	-202.80%	-224.00%	-254.80%	-239.40%	-595.70%	-
Return on Assets (ROA)	-92.00%	-82.30%	-143.10%	-112.80%	-105.70%	-
Return on Capital (ROIC)	-95.60%	-77.03%	-245.62%	-97.91%	-85.73%	-78.10%
Earnings Yield	-139.12%	-125.35%	-80.52%	-13.24%	-	-
FCF Yield	-35.62%	-50.75%	-36.86%	-7.85%	-	-
Buyback Yield / Dilution	-194.36%	-36.92%	-26.39%	-27.07%	-12.67%	-
Total Shareholder Return	-194.36%	-36.92%	-26.39%	-27.07%	-12.67%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).